PRECISION-MEDICINE

The mental health system treats everyone the same way: try something, wait six weeks, and if it doesn't work, try something else. We use data to skip the guessing.

Precision mental health means getting the right person to the right treatment the first time. Not the third time. Not after they've given up. The first time.

We went public in 2024 at a $6 billion valuation. For a precision medicine company. Not a drug company — a data company that helps doctors choose the right drug. That's a new category.

Every cancer tumor has a unique genetic signature. Sequencing that signature is how we personalize treatment.

Genome sequencing plus cancer screening equals personalized medicine. We're building that future.

If we can sequence a patient's tumor and their blood in real time and have a treatment decision by the next morning, we will save lives. That is the system we are building.